Riskpilot← Back to searchSign inGet full accessCresponix AB
ABActiveOrg 5592713803Vimpelgatan 1 B Lgh 1101Freshwater aquaculture · NACE 0322Est. 20200 employees
Revenue 2024
SEK 534K
+75185% vs 2023
EBITDA margin
-126.1%
+17% vs 2023
Equity ratio
90.6%
Financial strength
Net profit 2024
SEK -767K
+5% vs 2023
| Revenue | SEK 534K | +75185% |
| EBITDA | SEK -673K | +17% |
| Net profit | SEK -767K | +5% |
| Total assets | SEK 1,4M | -32% |
| Equity | SEK 1,3M | -37% |
| Employees | 0 | — |
Legal name
Cresponix AB
Org number
5592713803
Legal form
Aktiebolag
NACE code
0322 · Freshwater aquaculture
Founded
15 september 2020
Share capital
SEK 56 800
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska utföra landbaserad fiskodlingsverksamhet i sötvatten. Fiskarten Nile Tilapia kommer att odlas. Företaget har expasions visoner att odla andra fiskarter, samt kombinera verksamheten med produktion av grönsaker genom akvaponi. Försäljning kommer ske genom en grossist till lokala krögare. Lokala mataffärer och komunala verksamheter ses som framtida kundsegment
Address
Vimpelgatan 1 B Lgh 1101
Email
mattias.djurstedt@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 20 | 0 | 1 | 534 |
| Staff expenses | — | −5 | −7 | −2 |
| EBITDA | 28 | −188 | −807 | −673 |
| Depreciation & amort. | −0 | — | — | −94 |
| EBIT | 28 | −188 | −807 | −767 |
| Net financials | — | — | 0 | 0 |
| Profit before tax | 28 | −188 | −807 | −767 |
| Tax | −6 | — | — | — |
| Net profit | 22 | −188 | −807 | −767 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 78 | 2 882 | 2 099 | 1 436 |
| Equity | 72 | 2 876 | 2 069 | 1 302 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 6 | 6 | 30 | 134 |
| Total debt | 6 | 6 | 30 | 134 |
EBITDA margin
-126.1%
This company
15.8%
Market median
-898% vs market
20212024
Equity ratio
90.6%
This company
38.2%
Market median
+137% vs market
20212024
Return on equity
-58.9%
This company
18.4%
Market median
-420% vs market
20212024
Net profit margin
-143.7%
This company
8.1%
Market median
-1874% vs market
20212024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20212024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cresponix AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mattias August Djurstedt | Chairman | 0 companies |
| Sergio Zimmermann | Board of Directors | 0 companies |
| Karl Anders Kiessling | Board of Directors | 0 companies |